Advanced BioScience Laboratories, Inc (ABL) is a CDMO/CRO providing GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines and other immunotherapeutics Advanced BioScience Laboratories (ABL) is a leading international Washington, DC-based contract research and manufacturing organization experienced in partnering with clients to meet their preclinical and clinical produ
ct development goals. ABL’s long history of developmental partnerships in discovery includes enabling the initial characterization of the HIV-1 virus and the development of the first HIV-1 blood test. ABL assists clients with the design and development of their therapeutics and vaccines by offering a wide array of development services, including in vivo screening (rodents, rabbits, and nonhuman primates), ex vivo/in vitro assay services, turn-key project management and outsourcing support, and cGMP manufacturing of clinical trial material. ABL has been producing cGMP material since 1985 and continues to invest and expand these capabilities. Our new production facility has been designed with multiple production suites supporting mammalian expression, microbial expression, and viral vector operations. ABL is a unique contract service provider who strives to become a seamless extension of our client’s product development group to help them advance today’s ideas to tomorrow’s medicines.
